NihBiotechGrantPulse / compare

CRIMSON BIOPHARM INC vs MASSACHUSETTS GENERAL HOSPITAL: NihBiotechGrantPulse comparison

CRIMSON BIOPHARM INC's award of $1,125,000 is 1.0x MASSACHUSETTS GENERAL HOSPITAL's $1,114,075 (89th percentile). CRIMSON BIOPHARM INC is dated 2026-09-17; MASSACHUSETTS GENERAL HOSPITAL 2026-09-08.

Data as of · Compiled by Zalwin from NIH RePORTER (newly awarded projects)

Both records plus every comparable MA record, with all columns and source links · Card, Apple Pay, Google Pay or Link via Stripe

How does CRIMSON BIOPHARM INC compare to MASSACHUSETTS GENERAL HOSPITAL?

FieldCRIMSON BIOPHARM INCMASSACHUSETTS GENERAL HOSPITAL
OrganizationCRIMSON BIOPHARM INCMASSACHUSETTS GENERAL HOSPITAL
LocationBrookline, MABOSTON, MA
ProjectTargeting EGFR-Mutant NSCLC CNS Metastases with CM93, a Novel Brain-Penetrant EGFR InhibitorIntegrated analysis of HBV-specific CD4 T cell and B cell responses to define their role in chronic hepatitis B and HBV functional cure.
Project number2R42CA281586-025R01AI184931-03
MechanismR42R01
InstituteNational Cancer InstituteNational Institute of Allergy and Infectious Diseases
Award$1,125,000$1,114,075
Awarded2026-09-172026-09-08
Project period2026-09-22 to 2028-08-312024-07-01 to 2029-05-31
UEIZPMLH22W5Y81FLJ7DQKLL226
award percentile89th89th
Lab Budget Score70/10070/100
Peer rank and all 500 MA records (CSV) 🔒 Click to unlock →
Official source URLs for every peer record 🔒 Click to unlock →

Official records: CRIMSON BIOPHARM INC · MASSACHUSETTS GENERAL HOSPITAL

Get newly funded labs in your territory

NihBiotechGrantPulse emails new awards matching your states, mechanisms and minimum award.

See plans

Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.

Often used together